{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:12:32Z","timestamp":1772514752618,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,25]]},"DOI":"10.7759\/cureus.21586","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T13:00:27Z","timestamp":1643115627000},"source":"Crossref","is-referenced-by-count":4,"title":["Hereditary Coproporphyria Mimicking Guillain-Barr\u00e9 Syndrome After COVID-19 Infection"],"prefix":"10.7759","author":[{"given":"Margaret","family":"Upchurch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Deremiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen","family":"Barthol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaheryar","family":"Hafeez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl E","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Seifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2700.136847","article-title":"Acute flaccid paralysis in adults: our experience","volume":"7","author":"Kaushik R","year":"2014","unstructured":"Kaushik R, Kharbanda PS, Bhalla A, Rajan R, Prabhakar S. Acute flaccid paralysis in adults: our experience. J Emerg Trauma Shock. 2014, 7:149-54. 10.4103\/0974-2700.136847","journal-title":"J Emerg Trauma Shock"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.142","article-title":"Guillain-Barr\u00e9 syndrome, transverse myelitis and infectious diseases","volume":"15","author":"Rodr\u00edguez Y","year":"2018","unstructured":"Rodr\u00edguez Y, Rojas M, Pacheco Y, et al.. Guillain-Barr\u00e9 syndrome, transverse myelitis and infectious diseases. Cell Mol Immunol. 2018, 15:547-62. 10.1038\/cmi.2017.142","journal-title":"Cell Mol Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.960","article-title":"Guillain-Barr\u00e9 syndrome mimics","volume":"8","author":"Tham SL","year":"2018","unstructured":"Tham SL, Prasad K, Umapathi T. Guillain-Barr\u00e9 syndrome mimics. Brain Behav. 2018, 8:e00960. 10.1002\/brb3.960","journal-title":"Brain Behav"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-012-2464-9","article-title":"An atypical case of Guillain-Barr\u00e9 syndrome: acute intermittent porphyria","volume":"38","author":"Cuquemelle \u00c9","year":"2012","unstructured":"Cuquemelle \u00c9, Ehrmann S, Razazi K, Deybach JC, Brun-Buisson C, Thille AW. An atypical case of Guillain-Barr\u00e9 syndrome: acute intermittent porphyria. Intensive Care Med. 2012, 38:913-4. 10.1007\/s00134-012-2464-9","journal-title":"Intensive Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.17925\/USN.2020.16.1.66","article-title":"Porphyria-induced recurrent quadriplegia misdiagnosed as Guillain-Barr\u00e9 syndrome","volume":"16","author":"Rad N","year":"2020","unstructured":"Rad N, Beydoun SR. Porphyria-induced recurrent quadriplegia misdiagnosed as Guillain-Barr\u00e9 syndrome. US Neurol. 2020, 16:66-9. 10.17925\/USN.2020.16.1.66","journal-title":"US Neurol"},{"key":"ref6","article-title":"A case of acute intermittent porphyria mimicking Guillain-Barr\u00e9 syndrome","volume":"56","author":"Mutluay B","year":"2019","unstructured":"Mutluay B, K\u00f6ksal A, \u00c7el\u0131k RG, B\u00fclb\u00fcl HH. A case of acute intermittent porphyria mimicking Guillain-Barr\u00e9 syndrome. Noro Psikiyatr Ars. 2019, 56:311-2.","journal-title":"Noro Psikiyatr Ars"},{"key":"ref7","article-title":"The porphyrias","author":"Phillips JD","year":"2021","unstructured":"Phillips JD, Anderson KE. The porphyrias. Williams Hematology. Kaushansky K, Prchal JT, Burns LJ, Lichtman MA, Levi M, Linch DC (ed): McGraw Hill,  New York, NY; 2021."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2000.00653.x","article-title":"Could attacks of abdominal pain in cases of acute intermittent porphyria be due to intestinal angina?","volume":"247","author":"Lithner F","year":"2000","unstructured":"Lithner F. Could attacks of abdominal pain in cases of acute intermittent porphyria be due to intestinal angina?. J Intern Med. 2000, 247:407-9. 10.1046\/j.1365-2796.2000.00653.x","journal-title":"J Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000330683","article-title":"Neurological complications of acute intermittent porphyria","volume":"66","author":"Kuo HC","year":"2011","unstructured":"Kuo HC, Huang CC, Chu CC, et al.. Neurological complications of acute intermittent porphyria. Eur Neurol. 2011, 66:247-52. 10.1159\/000330683","journal-title":"Eur Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.06.036","article-title":"Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium","volume":"127","author":"Bonkovsky HL","year":"2014","unstructured":"Bonkovsky HL, Maddukuri VC, Yazici C, et al.. Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium. Am J Med. 2014, 127:1233-41. 10.1016\/j.amjmed.2014.06.036","journal-title":"Am J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14459","article-title":"Update review of the acute porphyrias","volume":"176","author":"Stein PE","year":"2017","unstructured":"Stein PE, Badminton MN, Rees DC. Update review of the acute porphyrias. Br J Haematol. 2017, 176:527-38. 10.1111\/bjh.14459","journal-title":"Br J Haematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-020-01078-8","article-title":"Porphyric neuropathy: pathophysiology, diagnosis, and updated management","volume":"20","author":"Kazamel M","year":"2020","unstructured":"Kazamel M, Desnick RJ, Quigley JG. Porphyric neuropathy: pathophysiology, diagnosis, and updated management. Curr Neurol Neurosci Rep. 2020, 20:56. 10.1007\/s11910-020-01078-8","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-008-0094-y","article-title":"Physicochemical properties, pharmacokinetics, and pharmacodynamics of intravenous hematin: a literature review","volume":"25","author":"Siegert SW","year":"2008","unstructured":"Siegert SW, Holt RJ. Physicochemical properties, pharmacokinetics, and pharmacodynamics of intravenous hematin: a literature review. Adv Ther. 2008, 25:842-57. 10.1007\/s12325-008-0094-y","journal-title":"Adv Ther"},{"key":"ref14","article-title":"Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools","volume":"86","author":"Bonkovsky HL","year":"1991","unstructured":"Bonkovsky HL, Healey JF, Lourie AN, Gerron GG. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools. Am J Gastroenterol. 1991, 86:1050-6.","journal-title":"Am J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913147","article-title":"Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria","volume":"382","author":"Balwani M","year":"2020","unstructured":"Balwani M, Sardh E, Ventura P, et al.. Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria. N Engl J Med. 2020, 382:2289-301. 10.1056\/NEJMoa1913147","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114432","article-title":"The growth of siRNA-based therapeutics: updated clinical studies","volume":"189","author":"Zhang MM","year":"2021","unstructured":"Zhang MM, Bahal R, Rasmussen TP, Manautou JE, Zhong XB. The growth of siRNA-based therapeutics: updated clinical studies. Biochem Pharmacol. 2021, 189:114432. 10.1016\/j.bcp.2021.114432","journal-title":"Biochem Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2010986","article-title":"Givosiran \u2014 running RNA interference to fight porphyria attacks","volume":"382","author":"Gonzalez-Aseguinolaza G","year":"2020","unstructured":"Gonzalez-Aseguinolaza G. Givosiran \u2014 running RNA interference to fight porphyria attacks. N Engl J Med. 2020, 382:2366-7. 10.1056\/NEJMe2010986","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.04.004","article-title":"Renal function decline with small interfering RNA silencing aminolevulinic acid synthase 1 (ALAS1)","volume":"6","author":"Lazareth H","year":"2021","unstructured":"Lazareth H, Poli A, Bignon Y, et al.. Renal function decline with small interfering RNA silencing aminolevulinic acid synthase 1 (ALAS1). Kidney Int Rep. 2021, 6:1904-11. 10.1016\/j.ekir.2021.04.004","journal-title":"Kidney Int Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12391","article-title":"Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or givosiran","volume":"44","author":"To-Figueras J","year":"2021","unstructured":"To-Figueras J, Wijngaard R, Garc\u00eda-Villoria J, et al.. Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or givosiran. J Inherit Metab Dis. 2021, 44:961-71. 10.1002\/jimd.12391","journal-title":"J Inherit Metab Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17060","article-title":"Abnormal concentration of porphyrins in serum from COVID-19 patients","volume":"190","author":"San Juan I","year":"2020","unstructured":"San Juan I, Bruzzone C, Bizkarguenaga M, et al.. Abnormal concentration of porphyrins in serum from COVID-19 patients. Br J Haematol. 2020, 190:e265-7. 10.1111\/bjh.17060","journal-title":"Br J Haematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1734279","article-title":"Impact of COVID-19 on rare diseases: report of three cases of acute hepatic porphyria affected by the pandemic","volume":"59","author":"Stadlbauer V","year":"2021","unstructured":"Stadlbauer V, Jud P, Hackl G, Reisinger AC, Eller P, Horvath A. Impact of COVID-19 on rare diseases: report of three cases of acute hepatic porphyria affected by the pandemic. Z Gastroenterol. 2021, 59:e347. 10.1055\/s-0041-1734279","journal-title":"Z Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/77553-hereditary-coproporphyria-mimicking-guillain-barr-syndrome-after-covid-19-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:23Z","timestamp":1707507803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/77553-hereditary-coproporphyria-mimicking-guillain-barr-syndrome-after-covid-19-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.21586","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,25]]}}}